Specimens of all labeling which has not been previously submitted during the PMTA, prior postmarket reports, or below segment 905(i) of your FD&C Act and descriptions of all labeling changes such as the day the labeling was very first disseminated and the day when dissemination was completely terminated.As Element of the chance analysis, FDA sugges